Zajac et al. [31] demonstrated a relationship between NPM1.3 transcript expression with NPM1 mutation and patient outcome only in a subgroup of NK-AML patients, constituting half of the entire studied cohort. Here, NPM1 is linked to acute myeloid leukemia.